Establishment of iPSC (KRIBBi001-A) from CD34+ group O D-negative bone marrow blood

Jieun Kim; Hyebin Koh; Xing Zhen; Dong Seok Lee; Hye Yeong Ha; Jong Hee Lee

doi:10.1016/j.scr.2021.102199

Establishment of iPSC (KRIBBi001-A) from CD34⁺ group O D-negative bone marrow blood

Jieun Kim
, Hyebin Koh
, Xing Zhen
, Dong Seok Lee
, Hye Yeong Ha
, Jong Hee Lee

Korea Research Institute of Bioscience and Biotechnology
The Catholic University of Korea
Kyungpook National University
Korea National Institute of Health

Research output: Contribution to journal › Article › peer-review

8 Scopus citations

Abstract

Human induced pluripotent stem cells with indefinite propagation in vitro provide a potential donor source of cells including erythroid cells for human therapy. Since group O D-negative (RhD⁻) blood cells are considered as universal donors for transfusion, it is compelling to derive iPSC line from group O/RhD⁻ sample as a new cellular source to generate universal RBCs. The resulting iPSC line derived from group O/RhD⁻ somatic source showed typical features of pluripotent stem cells and could provide an unprecedented cellular tool to develop universal therapeutics for blood transfusion.

Original language	English
Article number	102199
Journal	Stem Cell Research
Volume	51
DOIs	https://doi.org/10.1016/j.scr.2021.102199
State	Published - Mar 2021

Access to Document

10.1016/j.scr.2021.102199

Cite this

@article{a6ab4472b7b34756a12859b33126cf02,

title = "Establishment of iPSC (KRIBBi001-A) from CD34+ group O D-negative bone marrow blood",

abstract = "Human induced pluripotent stem cells with indefinite propagation in vitro provide a potential donor source of cells including erythroid cells for human therapy. Since group O D-negative (RhD−) blood cells are considered as universal donors for transfusion, it is compelling to derive iPSC line from group O/RhD− sample as a new cellular source to generate universal RBCs. The resulting iPSC line derived from group O/RhD− somatic source showed typical features of pluripotent stem cells and could provide an unprecedented cellular tool to develop universal therapeutics for blood transfusion.",

author = "Jieun Kim and Hyebin Koh and Xing Zhen and Lee, \{Dong Seok\} and Ha, \{Hye Yeong\} and Lee, \{Jong Hee\}",

note = "Publisher Copyright: {\textcopyright} 2021 The Author(s)",

year = "2021",

month = mar,

doi = "10.1016/j.scr.2021.102199",

language = "English",

volume = "51",

journal = "Stem Cell Research",

issn = "1873-5061",

publisher = "Elsevier B.V.",

}

TY - JOUR

T1 - Establishment of iPSC (KRIBBi001-A) from CD34+ group O D-negative bone marrow blood

AU - Kim, Jieun

AU - Koh, Hyebin

AU - Zhen, Xing

AU - Lee, Dong Seok

AU - Ha, Hye Yeong

AU - Lee, Jong Hee

PY - 2021/3

Y1 - 2021/3

N2 - Human induced pluripotent stem cells with indefinite propagation in vitro provide a potential donor source of cells including erythroid cells for human therapy. Since group O D-negative (RhD−) blood cells are considered as universal donors for transfusion, it is compelling to derive iPSC line from group O/RhD− sample as a new cellular source to generate universal RBCs. The resulting iPSC line derived from group O/RhD− somatic source showed typical features of pluripotent stem cells and could provide an unprecedented cellular tool to develop universal therapeutics for blood transfusion.

AB - Human induced pluripotent stem cells with indefinite propagation in vitro provide a potential donor source of cells including erythroid cells for human therapy. Since group O D-negative (RhD−) blood cells are considered as universal donors for transfusion, it is compelling to derive iPSC line from group O/RhD− sample as a new cellular source to generate universal RBCs. The resulting iPSC line derived from group O/RhD− somatic source showed typical features of pluripotent stem cells and could provide an unprecedented cellular tool to develop universal therapeutics for blood transfusion.

UR - https://www.scopus.com/pages/publications/85099927696

U2 - 10.1016/j.scr.2021.102199

DO - 10.1016/j.scr.2021.102199

M3 - Article

C2 - 33529979

AN - SCOPUS:85099927696

SN - 1873-5061

VL - 51

JO - Stem Cell Research

JF - Stem Cell Research

M1 - 102199

ER -

Establishment of iPSC (KRIBBi001-A) from CD34⁺ group O D-negative bone marrow blood

Abstract

Access to Document

Other files and links

Fingerprint

Cite this